Ignite Creation Date:
2025-12-25 @ 3:25 AM
Ignite Modification Date:
2025-12-26 @ 2:05 AM
Study NCT ID:
NCT05559905
Status:
COMPLETED
Last Update Posted:
2025-07-18
First Post:
2022-09-26
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Respiratory Syncytial Virus (RSV) Human Challenge Study of Molnupiravir in Healthy Participants (MK-4482-017)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-02
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-08
Completion Date Type:
ACTUAL
First Submit Date:
2022-09-26
First Submit QC Date:
None
Study First Post Date:
2022-09-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-04-16
Results First Submit QC Date:
None
Results First Post Date:
2024-05-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-08
Last Update Post Date:
2025-07-18
Last Update Post Date Type:
ACTUAL